Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:1262-1268
Published online before print February 21, 2008, doi: 10.1161/STROKEAHA.107.496448
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/4/1262    most recent
STROKEAHA.107.496448v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kleinschnitz, C.
Right arrow Articles by Stoll, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleinschnitz, C.
Right arrow Articles by Stoll, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HEPARIN
Related Collections
Right arrow Antiplatelets
Right arrow Arterial thrombosis
Right arrow Coagulation
Right arrow Heparin
Right arrow Other Treatment
Right arrow Animal models of human disease

(Stroke. 2008;39:1262.)
© 2008 American Heart Association, Inc.


Original Contributions

Blocking of Platelets or Intrinsic Coagulation Pathway–Driven Thrombosis Does Not Prevent Cerebral Infarctions Induced by Photothrombosis

Christoph Kleinschnitz, MD; Stefan Braeuninger, MD; Mirko Pham, MD; Madeleine Austinat, PhD; Ingo Nölte, MD; Thomas Renné, MD, PhD; Bernhard Nieswandt, PhD; Martin Bendszus, MD Guido Stoll, MD

From the Departments of Neurology (C.K., S.B., M.A., G.S.), Neuroradiology (M.P., I.N., M.B.), Clinical Biochemistry and Pathophysiology (T.R., B.N.), and the Rudolf Virchow Center for Experimental Biomedicine (B.N.), University of Würzburg, Germany.

Correspondence to Guido Stoll, MD, Department of Neurology, University of Würzburg, Josef-Schneider-Str 11, D-97080 Würzburg, Germany. E-mail stoll_g{at}klinik.uni-wuerzburg.de

Background and Purpose— Models of photochemically-induced thrombosis are widely used in cerebrovascular research. Photothrombotic brain infarctions can be induced by systemic application of photosensitizing dyes followed by focal illumination of the cerebral cortex. Although the ensuing activation of platelets is well established, their contribution for thrombosis and tissue damage has not formally been proved.

Methods— Infarction to the cerebral cortex was induced in mice by Rose Bengal and a cold light source. To assess the functional role of platelets, animals were platelet-depleted by anti-GPIb{alpha} antibodies or treated with GPIIb/IIIa-blocking F(ab)2 fragments. The significance of the plasmatic coagulation cascade was determined by using blood coagulation factor XII (FXII)-deficient mice or heparin. Infarct development and infarct volumes were determined by serial MRI and conventional and electron microscopy.

Results— There was no difference in development and final size of photothrombotic infarctions in mice with impaired platelet function. Moreover, deficiency of FXII, which initiates the intrinsic pathway of coagulation and is essential for thrombus formation, or blockade of FXa, the key protease during the waterfall cascade of plasmatic coagulation, by heparin likewise did not affect lesion development.

Conclusions— Our data demonstrate that platelet activation, factor XII–driven thrombus formation, and plasmatic coagulation pathways downstream of FX are not a prerequisite for ensuing tissue damage in models of photothrombotic vessel injury indicating that other pathomechanisms are involved. We suggest that this widely used model does not depend on platelet- or plasmatic coagulation-derived thrombosis.


Key Words: coagulation factor XII • GPIb • GPIIb/IIIa • photothrombosis • platelets